Using real-world drug utilization to estimate tumor necrosis factor blocker cost for treated psoriasis patients in a managed care setting

doi:10.1016/j.jaad.2011.11.863

Using real-world drug utilization to estimate tumor necrosis factor blocker cost for treated psoriasis patients in a managed care setting

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2011.11.863 ◽

2012 ◽

Vol 66 (4) ◽

pp. AB206

Keyword(s):

Tumor Necrosis Factor ◽

Managed Care ◽

Drug Utilization ◽

Real World ◽

Tumor Necrosis ◽

Care Setting ◽

Tumor Necrosis Factor Blocker ◽

Necrosis Factor

Download Full-text

PMS16 Cost of Tumor Necrosis Factor Blocker Per Treated Psoriatic Arthritis Patient Using Drug Utilization Data from a US Managed Care Population

Value in Health ◽

10.1016/j.jval.2012.03.205 ◽

2012 ◽

Vol 15 (4) ◽

pp. A36

Author(s):

M. Bonafede ◽

C. Watson ◽

S.R. Gandra ◽

N. Princic ◽

K.M. Fox

Keyword(s):

Psoriatic Arthritis ◽

Tumor Necrosis Factor ◽

Managed Care ◽

Drug Utilization ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Blocker ◽

Utilization Data ◽

Necrosis Factor

Download Full-text

Tumor necrosis factor blocker treatment patterns after discontinuation within the first year of therapy initiation in psoriatic arthritis patients in a real-world managed care setting

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2011.11.860 ◽

2012 ◽

Vol 66 (4) ◽

pp. AB205

Keyword(s):

Psoriatic Arthritis ◽

Tumor Necrosis Factor ◽

Managed Care ◽

Real World ◽

Tumor Necrosis ◽

Care Setting ◽

Treatment Patterns ◽

First Year ◽

Therapy Initiation ◽

Necrosis Factor

Download Full-text

Cost of tumor necrosis factor blocker per treated psoriatic arthritis patient using drug utilization data from a US managed care population

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2011.11.793 ◽

2012 ◽

Vol 66 (4) ◽

pp. AB189

Keyword(s):

Psoriatic Arthritis ◽

Tumor Necrosis Factor ◽

Managed Care ◽

Drug Utilization ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Blocker ◽

Utilization Data ◽

Necrosis Factor

Download Full-text

PMS69 Tumor Necrosis Factor Blocker Dose Escalation among Biologic Naïve Rheumatoid Arthritis (RA) Patients in Commercial Managed Care Plans in the Two Years Following Therapy Initiation

Value in Health ◽

10.1016/j.jval.2012.03.258 ◽

2012 ◽

Vol 15 (4) ◽

pp. A46

Author(s):

M. Bonafede ◽

S.R. Gandra ◽

K.M. Fox ◽

K. Wilson

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Managed Care ◽

Dose Escalation ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Blocker ◽

Care Plans ◽

Therapy Initiation ◽

Necrosis Factor

Download Full-text

Costs of tumor necrosis factor blockers per treated patient with psoriatic disease using real-world drug usation data in a US managed care population

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2012.12.810 ◽

2013 ◽

Vol 68 (4) ◽

pp. AB196

Keyword(s):

Tumor Necrosis Factor ◽

Managed Care ◽

Real World ◽

Tumor Necrosis ◽

Treated Patient ◽

Psoriatic Disease ◽

Necrosis Factor

Download Full-text

SAT0143 Tumor necrosis factor-blocker use in us managed care: Utilization and dosing patterns among rheumatoid arthritis patients:

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.3090 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 520.1-520

Author(s):

M. Fisher ◽

C. Watson ◽

K.M. Fox ◽

Y.-W. Chen ◽

S.R. Gandra

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Managed Care ◽

Tumor Necrosis ◽

Care Utilization ◽

Tumor Necrosis Factor Blocker ◽

Necrosis Factor ◽

Dosing Patterns

Download Full-text

Real world tumor necrosis factor (TNF) blocker treatment patterns for biologic-naïve psoriasis patients in a US managed care population

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2011.11.051 ◽

2012 ◽

Vol 66 (4) ◽

pp. AB10

Keyword(s):

Tumor Necrosis Factor ◽

Managed Care ◽

Real World ◽

Tumor Necrosis ◽

Treatment Patterns ◽

Tnf Blocker ◽

Necrosis Factor

Download Full-text

Costs of Tumor Necrosis Factor Blockers Per Treated Patient Using Real-World Drug Data in a Managed Care Population

Journal of Managed Care Pharmacy ◽

10.18553/jmcp.2013.19.8.621 ◽

2013 ◽

Vol 19 (8) ◽

pp. 621-630 ◽

Cited By ~ 18

Author(s):

Vernon F. Schabert ◽

Crystal Watson ◽

George J. Joseph ◽

Paige Iversen ◽

Chakkarin Burudpakdee ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Managed Care ◽

Real World ◽

Tumor Necrosis ◽

Treated Patient ◽

Necrosis Factor

Download Full-text

PMS56 PHARMACY REFILL PATTERNS FOR SUBCUTANEOUS ANTI-TUMOR NECROSIS FACTOR AGENTS USED IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN A MANAGED CARE SETTING

Value in Health ◽

10.1016/s1098-3015(10)73431-8 ◽

2009 ◽

Vol 12 (3) ◽

pp. A74

Author(s):

C Carter ◽

B Tang ◽

A Changolkar ◽

RS McKenzie ◽

CT Piech

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Managed Care ◽

Tumor Necrosis ◽

Care Setting ◽

Pharmacy Refill ◽

Necrosis Factor

Download Full-text

Tumor necrosis factor blocker dose escalation among biologic naïve rheumatoid arthritis patients in commercial managed-care plans in the 2 years following therapy initiation

Journal of Medical Economics ◽

10.3111/13696998.2012.667028 ◽

2012 ◽

Vol 15 (4) ◽

pp. 635-643 ◽

Cited By ~ 16

Author(s):

Machaon M.K. Bonafede ◽

Shravanthi R. Gandra ◽

Kathleen M. Fox ◽

Kathleen L. Wilson

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Managed Care ◽

Dose Escalation ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Blocker ◽

Care Plans ◽

Therapy Initiation ◽

Necrosis Factor

Download Full-text